The Angiotensin II Type 1 Receptor Blocker Candesartan Attenuates Graft Vasculopathy

Journal of Surgical Research

Volumn 132, Issue 1, 2006, Pages 62-68

  Yamamoto, Tetsufumi ^a   Sata, Masataka ^a,b   Fukuda, Daiju ^a   Takamoto, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

angiotensin II; arteriosclerosis; progenitor; smooth muscle cell; transplantation

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CANDESARTAN; CELL ADHESION MOLECULE; CYTOKINE; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HEART; HEART TRANSPLANTATION; INTIMA; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIOSCLEROSIS; BENZIMIDAZOLES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED DBA; MICE, INBRED STRAINS; POSTOPERATIVE COMPLICATIONS; TETRAZOLES; TRANSPLANTATION CHIMERA; TUNICA INTIMA; VASCULAR DISEASES;

EID: 33645999083     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.07.011     Document Type: Article

References (38)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Keck B.M., and Hertz M.I. The Registry of the International Society for Heart and Lung Transplantation. Twenty-first official adult heart transplant report-2004. J. Heart Lung Transplant 23 (2004) 796
2. John R., Rajasinghe H.A., Chen J.M., et al. Long-term outcomes after cardiac transplantation. An experience based on different eras of immunosuppressive therapy. Ann. Thorac. Surg. 72 (2001) 440
3. Billingham M.E. Cardiac transplant atherosclerosis. Transplant. Proc. 19 (1987) 19
4. Wagenaar L.J., Voors A.A., Buikema H., and van Gilst W.H. Angiotensin receptors in the cardiovascular system. Can. J. Cardiol. 18 (2002) 1331
5. Candido R., Allen T.J., Lassila M., et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109 (2004) 1536
6. Zou Y., Akazawa H., Qin Y., et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell Biol. 6 (2004) 499
7. Corry R.J., Winn H.J., and Russell P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16 (1973) 343
8. Saiura A., Sata M., Hirata Y., Nagai R., and Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 7 (2001) 382
9. Saiura A., Sata M., Washida M., et al. Little evidence for cell fusion between recipient and donor-derived cells. J. Surg. Res. 113 (2003) 222
10. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403
11. Koglin J., Glysing-Jensen T., Raisanen-Sokolowski A., and Russell M.E. Immune sources of transforming growth factor-beta1 reduce transplant arteriosclerosis. Insight derived from a knockout mouse model. Circ. Res. 83 (1998) 652
12. Okada S., Yoshida T., Hong Z., et al. Impairment of B lymphopoiesis in precocious aging (klotho) mice. Int. Immunol. 12 (2000) 861
13. Miconnet I., Bruley-Rosset M., and Halle-Pannenko O. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens. J. Immunol. 148 (1992) 3706
14. Hirozane T., Matsumori A., Furukawa Y., and Sasayama S. Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model. Circulation 91 (1995) 386
15. Furukawa Y., Matsumori A., Hirozane T., and Sasayama S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 93 (1996) 333
16. Ross R. Genetically modified mice as models of transplant atherosclerosis. Nat. Med. 2 (1996) 527
17. Kobayashi J., Crawford S.E., Backer C.L., et al. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. Circulation 88 (1993) II286
18. Dantas A.P., Franco Mdo C., Silva-Antonialli M.M., et al. Gender differences in superoxide generation in microvessels of hypertensive rats. Role of NAD(P)H-oxidase. Cardiovasc. Res. 61 (2004) 22
19. Richter M.H., Richter H.R., Olbrich H.G., and Mohr F.W. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation. Reduction of incidence and severity of transplant vasculopathy. Transpl. Int. 16 (2003) 26
20. Russell M.E., Adams D.H., Wyner L.R., Yamashita Y., Halnon N.J., and Karnovsky M.J. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc. Natl. Acad. Sci. USA 90 (1993) 6086
21. Wu L., Iwai M., Nakagami H., et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104 (2001) 2716
22. Takai S., Kim S., Sakonjo H., and Miyazaki M. Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet. J. Hypertens. 21 (2003) 361
23. Kiarash A., Pagano P.J., Tayeh M., Rhaleb N.E., and Carretero O.A. Upregulated expression of rat heart intercellular adhesion molecule-1 in Angiotensin II- but not phenylephrine-induced hypertension. Hypertension 37 (2001) 58
24. Isobe M., Yagita H., Okumura K., and Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255 (1992) 1125
25. Kimball P.M., Radovancevic B., Isom T., Spickard A., and Frazier O.H. The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation. Transplantation 61 (1996) 909
26. Schieffer B., Schieffer E., Hilfiker-Kleiner D., et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques. Potential implications for inflammation and plaque instability. Circulation 101 (2000) 1372
27. Ohki S., Iizuka K., Ishikawa S., et al. A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model. J. Heart Lung Transplant. 20 (2001) 956
28. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199
29. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346 (2002) 5
30. Glaser R., Lu M.M., Narula N., and Epstein J.A. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106 (2002) 17
31. Grimm P.C., Nickerson P., Jeffery J., et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N. Engl. J. Med. 345 (2001) 93
32. Caplice N.M., Bunch T.J., Stalboerger P.G., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl. Acad. Sci. USA 100 (2003) 4754
33. Billingham M.E., Cary N.R., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9 (1990) 587
34. Deb A., Skelding K.A., Wang S., Reeder M., Simper D., and Caplice N.M. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 110 (2004) 2673
35. Nahmod K.A., Vermeulen M.E., Raiden S., et al. Control of dendritic cell differentiation by angiotensin II. Faseb. J. 17 (2003) 491
36. Haznedaroglu I.C., Tuncer S., and Gursoy M. A local renin-angiotensin system in the bone marrow. Med. Hypotheses. 46 (1996) 507
37. Rodgers K.E., Xiong S., Steer R., and diZerega G.S. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 18 (2000) 287
38. Haznedaroglu I.C., and Ozturk M.A. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int. J. Biochem. Cell Biol. 35 (2003) 867